Integra LifeSciences Stock Price, News & Analysis (NASDAQ:IART)

$48.92 0.84 (1.75 %)
(As of 12/11/2017 09:54 AM ET)
Previous Close$48.08
Today's Range$47.92 - $48.94
52-Week Range$38.91 - $56.42
Volume495,800 shs
Average Volume593,414 shs
Market Capitalization$3.84 billion
P/E Ratio27.03
Dividend YieldN/A
Beta0.65

About Integra LifeSciences (NASDAQ:IART)

Integra LifeSciences logoIntegra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. Its segments include Specialty Surgical Solutions, which offers specialty surgical instrumentation for a range of specialties, including product portfolio used in the neurosurgery operating suite and critical care unit, and Orthopedics and Tissue Technologies, which includes differentiated soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement solutions. It sells products and solutions for dural repair, precision tools and instruments, tissue ablation and neuro critical care. It also sells regenerative technology products for treating acute wounds, such as burns, and chronic wounds, including diabetic foot ulcers and surgical tissue repair. Its products are used in neurosurgery, extremity reconstruction, orthopedics and general surgery.

Receive IART News and Ratings via Email

Sign-up to receive the latest news and ratings for IART and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:IART
CUSIP45798520
Phone609-275-0500

Debt

Debt-to-Equity Ratio1.26%
Current Ratio4.49%
Quick Ratio3.39%

Price-To-Earnings

Trailing P/E Ratio27.03
Forward P/E Ratio26.44
P/E Growth2.15

Sales & Book Value

Annual Sales$992.08 million
Price / Sales3.87
Cash Flow$2.81 per share
Price / Cash17.38
Book Value$11.23 per share
Price / Book4.36

Profitability

Trailing EPS$0.61
Net Income$74.56 million
Net Margins4.52%
Return on Equity16.35%
Return on Assets6.83%

Miscellaneous

Employees3,700
Outstanding Shares78,480,000

Integra LifeSciences (NASDAQ:IART) Frequently Asked Questions

What is Integra LifeSciences' stock symbol?

Integra LifeSciences trades on the NASDAQ under the ticker symbol "IART."

When did Integra LifeSciences' stock split? How did Integra LifeSciences' stock split work?

Shares of Integra LifeSciences split before market open on Tuesday, January 3rd 2017. The 2-1 split was announced on Thursday, December 22nd 2016. The newly issued shares were issued to shareholders after the market closes on Wednesday, December 21st 2016. An investor that had 100 shares of Integra LifeSciences stock prior to the split would have 200 shares after the split.

How were Integra LifeSciences' earnings last quarter?

Integra LifeSciences Holdings Corporation (NASDAQ:IART) released its quarterly earnings results on Thursday, October, 26th. The life sciences company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.47 by $0.02. The life sciences company had revenue of $278.83 million for the quarter, compared to analyst estimates of $286 million. Integra LifeSciences had a return on equity of 16.35% and a net margin of 4.52%. The firm's revenue for the quarter was up 11.4% compared to the same quarter last year. During the same quarter last year, the company earned $0.93 earnings per share. View Integra LifeSciences' Earnings History.

When will Integra LifeSciences make its next earnings announcement?

Integra LifeSciences is scheduled to release their next quarterly earnings announcement on Wednesday, February, 21st 2018. View Earnings Estimates for Integra LifeSciences.

Where is Integra LifeSciences' stock going? Where will Integra LifeSciences' stock price be in 2017?

10 brokers have issued 1 year target prices for Integra LifeSciences' stock. Their forecasts range from $44.00 to $65.00. On average, they anticipate Integra LifeSciences' stock price to reach $53.33 in the next twelve months. View Analyst Ratings for Integra LifeSciences.

Who are some of Integra LifeSciences' key competitors?

Who are Integra LifeSciences' key executives?

Integra LifeSciences' management team includes the folowing people:

  • Stuart M. Essig Ph.D., Independent Chairman of the Board (Age 55)
  • Peter J. Arduini, President, Chief Executive Officer, Director (Age 52)
  • Glenn G. Coleman, Chief Financial Officer, Corporate Vice President (Age 49)
  • Lisa Evoli, Corporate Vice President, Chief Human Resources Officer (Age 47)
  • Jeffrey Mosebrook, Principal Accounting Officer, Vice President, Corporate Controller (Age 41)
  • Kenneth Burhop Ph.D., Chief Scientific Officer, Corporate Vice President (Age 63)
  • John Mooradian, Corporate Vice President - Global Operations and Supply Chain (Age 61)
  • Richard D. Gorelick, Corporate Vice President, General Counsel, Administration, Secretary (Age 56)
  • Robert T. Davis Jr., Corporate Vice President, President — Specialty Surgical Solutions (Age 58)
  • Judith E. O'Grady R.N., Corporate Vice President - Global Regulatory Affairs (Age 66)

Who owns Integra LifeSciences stock?

Integra LifeSciences' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Janus Henderson Group PLC (2.59%), Dimensional Fund Advisors LP (1.89%), Orbimed Advisors LLC (1.39%), Jennison Associates LLC (1.32%), Fisher Asset Management LLC (1.29%) and Vaughan Nelson Investment Management L.P. (1.15%). Company insiders that own Integra LifeSciences stock include Barbara B Hill, Christian S Schade, Daniel L Reuvers, Donald E Morel Jr, Glenn Coleman, James M Sullivan, Jeffrey Mosebrook, Joseph Vinhais, Peter J Arduini, Raymond G Murphy, Richard D Gorelick and Stuart Essig. View Institutional Ownership Trends for Integra LifeSciences.

Who sold Integra LifeSciences stock? Who is selling Integra LifeSciences stock?

Integra LifeSciences' stock was sold by a variety of institutional investors in the last quarter, including Eagle Asset Management Inc., Wells Fargo & Company MN, Hood River Capital Management LLC, Victory Capital Management Inc., Boston Partners, Dimensional Fund Advisors LP, Artisan Partners Limited Partnership and BNP Paribas Arbitrage SA. Company insiders that have sold Integra LifeSciences company stock in the last year include Glenn Coleman, James M Sullivan, Jeffrey Mosebrook, Richard D Gorelick and Stuart Essig. View Insider Buying and Selling for Integra LifeSciences.

Who bought Integra LifeSciences stock? Who is buying Integra LifeSciences stock?

Integra LifeSciences' stock was acquired by a variety of institutional investors in the last quarter, including Orbimed Advisors LLC, Jennison Associates LLC, Chartwell Investment Partners LLC, Westfield Capital Management Co. LP, Sei Investments Co., Sector Gamma AS, First Trust Advisors LP and Schwab Charles Investment Management Inc.. Company insiders that have bought Integra LifeSciences stock in the last two years include Barbara B Hill and Donald E Morel Jr. View Insider Buying and Selling for Integra LifeSciences.

How do I buy Integra LifeSciences stock?

Shares of Integra LifeSciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Integra LifeSciences' stock price today?

One share of Integra LifeSciences stock can currently be purchased for approximately $48.92.

How big of a company is Integra LifeSciences?

Integra LifeSciences has a market capitalization of $3.84 billion and generates $992.08 million in revenue each year. The life sciences company earns $74.56 million in net income (profit) each year or $0.61 on an earnings per share basis. Integra LifeSciences employs 3,700 workers across the globe.

How can I contact Integra LifeSciences?

Integra LifeSciences' mailing address is 311 ENTERPRISE DRIVE, PLAINSBORO NJ, 08536. The life sciences company can be reached via phone at 609-275-0500 or via email at [email protected]


MarketBeat Community Rating for Integra LifeSciences (IART)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  266 (Vote Outperform)
Underperform Votes:  273 (Vote Underperform)
Total Votes:  539
MarketBeat's community ratings are surveys of what our community members think about Integra LifeSciences and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Integra LifeSciences (NASDAQ:IART) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.672.672.822.78
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $52.59$52.59$53.45$49.69
Price Target Upside: 7.81% upside7.81% upside0.34% downside0.39% downside

Integra LifeSciences (NASDAQ:IART) Consensus Price Target History

Price Target History for Integra LifeSciences (NASDAQ:IART)

Integra LifeSciences (NASDAQ:IART) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/9/2017Royal Bank Of CanadaReiterated RatingSector Perform -> Sector Perform$48.00 -> $50.00N/AView Rating Details
10/29/2017Wells Fargo & CompanyDowngradeOutperform -> Market PerformN/AView Rating Details
10/29/2017Jefferies GroupReiterated RatingBuy$56.00N/AView Rating Details
10/27/2017J P Morgan Chase & CoDowngradeOverweight -> Neutral$44.00N/AView Rating Details
10/26/2017OppenheimerReiterated RatingBuyN/AView Rating Details
9/12/2017BarclaysReiterated RatingEqual Weight$47.00 -> $53.00HighView Rating Details
7/27/2017Raymond James FinancialBoost Price TargetOutperform$51.00 -> $55.00LowView Rating Details
7/26/2017Cantor FitzgeraldSet Price TargetBuy$65.00LowView Rating Details
3/22/2017Piper Jaffray CompaniesReiterated RatingOverweight$47.00LowView Rating Details
1/6/2017JMP SecuritiesUpgradeMarket Perform -> Outperform$50.00N/AView Rating Details
10/28/2016Lake Street CapitalUpgradeHold -> Buy$46.00N/AView Rating Details
9/23/2016ArgusBoost Price TargetBuy$45.00 -> $52.50N/AView Rating Details
(Data available from 12/11/2015 forward)

Earnings

Integra LifeSciences (NASDAQ:IART) Earnings History and Estimates Chart

Earnings by Quarter for Integra LifeSciences (NASDAQ:IART)

Integra LifeSciences (NASDAQ IART) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/21/2018$0.56N/AView Earnings Details
10/26/2017Q3 2017$0.47$0.45$286.00 million$278.83 millionViewN/AView Earnings Details
7/26/2017Q2 2017$0.45$0.45$283.58 million$282.16 millionViewN/AView Earnings Details
4/26/2017Q1 17$0.40$0.39$254.19 million$258.60 millionViewN/AView Earnings Details
2/23/2017Q4 2016$0.52$0.52$257.27 million$255.70 millionViewN/AView Earnings Details
10/27/2016Q3$0.89$0.93$249.30 million$250.30 millionViewListenView Earnings Details
7/28/2016Q216$0.76$0.79$243.17 million$249.30 millionViewListenView Earnings Details
4/27/2016Q116$0.73$0.74$230.66 million$236.80 millionViewListenView Earnings Details
2/25/2016Q4$0.86$0.87$241.11 million$241.20 millionViewListenView Earnings Details
11/3/2015Q315$0.74$0.75$224.08 million$226.40 millionViewListenView Earnings Details
7/30/2015Q215$0.73$0.79$239.91 million$244.10 millionViewListenView Earnings Details
4/30/2015Q115$0.63$0.76$229.69 million$233.70 millionViewN/AView Earnings Details
2/24/2015Q414$0.89$0.94$244.39 million$252.20 millionViewListenView Earnings Details
11/3/2014Q314$0.74$0.76$233.50 million$229.70 millionViewListenView Earnings Details
8/5/2014Q214$0.63$0.68$229.32 million$231.40 millionViewN/AView Earnings Details
5/1/2014Q114$0.58$0.57$213.30 million$215.00 millionViewN/AView Earnings Details
2/25/2014Q413$0.81$0.78$223.37 million$220.80 millionViewN/AView Earnings Details
10/28/2013Q313$0.70$0.72$214.05 million$213.20 millionViewN/AView Earnings Details
8/1/2013Q2 2013$0.55$0.60$207.30 million$205.50 millionViewN/AView Earnings Details
5/2/2013Q1 2013$0.37$0.39$195.20 million$196.70 millionViewN/AView Earnings Details
2/21/2013Q4 2012$0.76$0.78$215.90 million$214.40 millionViewN/AView Earnings Details
10/24/2012$0.77$0.85ViewN/AView Earnings Details
7/26/2012$0.69$0.74ViewN/AView Earnings Details
4/25/2012$0.60$0.71ViewN/AView Earnings Details
2/23/2012$0.55$0.72ViewN/AView Earnings Details
10/31/2011$0.77$0.77ViewN/AView Earnings Details
7/28/2011$0.61$0.70ViewN/AView Earnings Details
4/28/2011$0.66$0.66ViewN/AView Earnings Details
2/24/2011$0.73$0.80ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Integra LifeSciences (NASDAQ:IART) Earnings Estimates

2017 EPS Consensus Estimate: $1.89
2018 EPS Consensus Estimate: $2.26
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$0.38$0.48$0.42
Q2 20174$0.43$0.47$0.45
Q3 20174$0.42$0.50$0.46
Q4 20174$0.55$0.60$0.57
Q1 20183$0.45$0.51$0.47
Q2 20183$0.54$0.56$0.55
Q3 20183$0.57$0.60$0.58
Q4 20183$0.61$0.70$0.65
Q1 20191$0.54$0.54$0.54
Q2 20191$0.62$0.62$0.62
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Integra LifeSciences (NASDAQ:IART)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Integra LifeSciences (NASDAQ IART) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 21.50%
Institutional Ownership Percentage: 87.62%
Insider Trades by Quarter for Integra LifeSciences (NASDAQ:IART)
Insider Trades by Quarter for Integra LifeSciences (NASDAQ:IART)

Integra LifeSciences (NASDAQ IART) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/20/2017Jeffrey MosebrookInsiderSell160$47.41$7,585.60View SEC Filing  
11/14/2017Richard D GorelickVPSell1,500$47.19$70,785.00View SEC Filing  
10/31/2017Barbara B HillDirectorBuy10,768$46.66$502,434.88View SEC Filing  
8/4/2017Donald E Morel JrDirectorBuy10,000$49.25$492,500.00View SEC Filing  
8/3/2017Donald E Morel JrDirectorBuy2,500$49.29$123,225.00View SEC Filing  
8/1/2017Barbara B HillDirectorBuy5,050$49.33$249,116.50View SEC Filing  
5/25/2017Stuart EssigDirectorSell135,000$49.90$6,736,500.00View SEC Filing  
5/23/2017Stuart EssigDirectorSell140,000$48.01$6,721,400.00View SEC Filing  
5/4/2017Glenn ColemanVPSell13,865$45.91$636,542.15View SEC Filing  
5/4/2017James M SullivanDirectorSell15,658$45.89$718,545.62View SEC Filing  
11/8/2016Peter J ArduiniCEOSell24,009$79.51$1,908,955.59View SEC Filing  
8/23/2016Raymond G MurphyDirectorSell2,600$86.64$225,264.00View SEC Filing  
8/9/2016Peter J ArduiniCEOSell24,009$84.52$2,029,240.68View SEC Filing  
8/4/2016Raymond G MurphyDirectorSell2,610$84.83$221,406.30View SEC Filing  
8/1/2016Richard D GorelickVPSell4,000$84.60$338,400.00View SEC Filing  
5/9/2016Joseph VinhaisVPSell972$73.36$71,305.92View SEC Filing  
5/4/2016Glenn ColemanCFOSell3,563$70.62$251,619.06View SEC Filing  
5/3/2016Christian S SchadeDirectorSell7,829$70.42$551,318.18View SEC Filing  
5/2/2016Daniel L ReuversVPSell1,000$71.43$71,430.00View SEC Filing  
4/29/2016Richard D GorelickVPSell4,000$70.72$282,880.00View SEC Filing  
4/27/2016Stuart EssigDirectorSell104,390$70.15$7,322,958.50View SEC Filing  
4/6/2016Stuart EssigDirectorSell21,100$66.19$1,396,609.00View SEC Filing  
4/5/2016Stuart EssigDirectorSell83,290$66.68$5,553,777.20View SEC Filing  
4/4/2016Stuart EssigDirectorSell42,150$67.26$2,835,009.00View SEC Filing  
5/7/2015Stuart EssigDirectorSell75,000$64.32$4,824,000.00View SEC Filing  
5/6/2015Stuart EssigDirectorSell125,000$64.83$8,103,750.00View SEC Filing  
1/2/2015Judith OgradyVPSell3,500$53.33$186,655.00View SEC Filing  
10/28/2014Stuart EssigDirectorSell147,098$49.58$7,293,118.84View SEC Filing  
10/27/2014Stuart EssigDirectorSell41,268$49.56$2,045,242.08View SEC Filing  
9/2/2014Judith OgradyVPSell2,500$49.82$124,550.00View SEC Filing  
8/27/2014Richard D GorelickVPSell7,000$50.03$350,210.00View SEC Filing  
8/25/2014John B Henneman IIICAOSell20,000$50.12$1,002,400.00View SEC Filing  
8/22/2014Deborah A LeonettiVPSell1,000$50.96$50,960.00View SEC Filing  
8/8/2014Brian LarkinVPSell1,947$48.28$94,001.16View SEC Filing  
7/30/2014Stuart EssigDirectorSell50,800$47.76$2,426,208.00View SEC Filing  
7/23/2014Stuart EssigDirectorSell27,819$47.80$1,329,748.20View SEC Filing  
7/1/2014Judith OgradyVPSell2,500$47.54$118,850.00View SEC Filing  
6/23/2014Stuart EssigDirectorSell21,381$47.76$1,021,156.56View SEC Filing  
4/3/2014Stuart EssigDirectorSell6,344$46.01$291,887.44View SEC Filing  
4/2/2014Stuart EssigDirectorSell76,177$46.05$3,507,950.85View SEC Filing  
3/31/2014Stuart EssigDirectorSell17,479$46.05$804,907.95View SEC Filing  
3/10/2014Deborah LeonettiVPSell7,563$49.22$372,250.86View SEC Filing  
3/4/2014Richard GorelickVPSell2,000$47.98$95,960.00View SEC Filing  
2/28/2014Christian SchadeDirectorSell7,500$47.06$352,950.00View SEC Filing  
2/27/2014Brian LarkinVPSell3,265$46.15$150,679.75View SEC Filing  
2/27/2014John Henneman IIICFOSell5,000$46.07$230,350.00View SEC Filing  
1/16/2014Stuart EssigDirectorSell8,037$49.59$398,554.83View SEC Filing  
1/14/2014Stuart EssigDirectorSell10,600$49.50$524,700.00View SEC Filing  
1/13/2014Stuart EssigDirectorSell99,032$49.51$4,903,074.32View SEC Filing  
1/9/2014Stuart EssigDirectorSell114,431$49.58$5,673,488.98View SEC Filing  
8/30/2013Richard GorelickVPSell3,000$40.79$122,370.00View SEC Filing  
8/23/2013Deborah LeonettiVPSell8,906$41.68$371,202.08View SEC Filing  
8/19/2013Brian LarkinVPSell7,490$41.90$313,831.00View SEC Filing  
8/19/2013John Henneman IIICFOSell30,000$42.08$1,262,400.00View SEC Filing  
8/1/2013Judith OgradyVPSell1,000$39.50$39,500.00View SEC Filing  
7/30/2013Judith OgradyVPSell2,000$38.50$77,000.00View SEC Filing  
5/31/2013Jerry E CorbinVPSell1,876$38.07$71,419.32View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Integra LifeSciences (NASDAQ IART) News Headlines

Source:
DateHeadline
Integra LifeSciences Hosts Investor Day 2017 New York CityIntegra LifeSciences Hosts Investor Day 2017 New York City
feeds.benzinga.com - December 11 at 8:03 AM
Integra LifeSciences Holdings Corp. – Value Analysis (NASDAQ:IART) : December 5, 2017Integra LifeSciences Holdings Corp. – Value Analysis (NASDAQ:IART) : December 5, 2017
finance.yahoo.com - December 5 at 3:33 PM
Integra LifeSciences Holdings Corp. breached its 50 day moving average in a Bullish Manner : IART-US : December 4, 2017Integra LifeSciences Holdings Corp. breached its 50 day moving average in a Bullish Manner : IART-US : December 4, 2017
finance.yahoo.com - December 4 at 11:12 AM
Integra (IART) Up 1.8% Since Earnings Report: Can It Continue?Integra (IART) Up 1.8% Since Earnings Report: Can It Continue?
finance.yahoo.com - November 27 at 5:27 PM
Integra LifeSciences Holdings Co. (IART) Receives Consensus Recommendation of "Buy" from AnalystsIntegra LifeSciences Holdings Co. (IART) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - November 19 at 11:54 AM
Analyzing VWR Corporation (VWR) & Integra LifeSciences Holdings (IART)Analyzing VWR Corporation (VWR) & Integra LifeSciences Holdings (IART)
www.americanbankingnews.com - November 19 at 9:40 AM
ETFs with exposure to Integra LifeSciences Holdings Corp. : November 16, 2017ETFs with exposure to Integra LifeSciences Holdings Corp. : November 16, 2017
finance.yahoo.com - November 17 at 5:22 AM
Insider Selling: Integra LifeSciences Holdings Corporation (IART) VP Sells 1,500 Shares of StockInsider Selling: Integra LifeSciences Holdings Corporation (IART) VP Sells 1,500 Shares of Stock
www.americanbankingnews.com - November 15 at 10:29 PM
Integra LifeSciences Holdings Corporation (IART) Expected to Announce Quarterly Sales of $361.17 MillionIntegra LifeSciences Holdings Corporation (IART) Expected to Announce Quarterly Sales of $361.17 Million
www.americanbankingnews.com - November 12 at 3:08 AM
Integra Gains on Global Growth, Hurricanes Hamper BusinessIntegra Gains on Global Growth, Hurricanes Hamper Business
finance.yahoo.com - November 3 at 8:24 AM
ETFs with exposure to Integra LifeSciences Holdings Corp. : November 2, 2017ETFs with exposure to Integra LifeSciences Holdings Corp. : November 2, 2017
finance.yahoo.com - November 3 at 8:24 AM
Integra LifeSciences Holdings Corp. :IART-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017Integra LifeSciences Holdings Corp. :IART-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017
finance.yahoo.com - November 2 at 1:32 AM
Insider Buying: Integra LifeSciences Holdings Corporation (IART) Director Purchases 10,768 Shares of StockInsider Buying: Integra LifeSciences Holdings Corporation (IART) Director Purchases 10,768 Shares of Stock
www.americanbankingnews.com - November 1 at 5:44 PM
Integra LifeSciences Holdings Corporation (IART) Forecasted to Earn FY2017 Earnings of $1.86 Per ShareIntegra LifeSciences Holdings Corporation (IART) Forecasted to Earn FY2017 Earnings of $1.86 Per Share
www.americanbankingnews.com - November 1 at 9:38 AM
Northcoast Research Weighs in on Integra LifeSciences Holdings Corporations Q3 2018 Earnings (IART)Northcoast Research Weighs in on Integra LifeSciences Holdings Corporation's Q3 2018 Earnings (IART)
www.americanbankingnews.com - October 31 at 2:02 PM
Integra LifeSciences Holdings Corporation (IART) to Post FY2019 Earnings of $2.59 Per Share, Oppenheimer Holdings ForecastsIntegra LifeSciences Holdings Corporation (IART) to Post FY2019 Earnings of $2.59 Per Share, Oppenheimer Holdings Forecasts
www.americanbankingnews.com - October 30 at 11:52 AM
Wells Fargo & Company Downgrades Integra LifeSciences Holdings Corporation (IART) to Market PerformWells Fargo & Company Downgrades Integra LifeSciences Holdings Corporation (IART) to Market Perform
www.americanbankingnews.com - October 30 at 12:46 AM
Integra LifeSciences Holdings Corporation 2017 Q3 - Results - Earnings Call SlidesIntegra LifeSciences Holdings Corporation 2017 Q3 - Results - Earnings Call Slides
seekingalpha.com - October 28 at 8:09 PM
Integra LifeSciences Holdings Corporation (IART) Stock Rating Lowered by TheStreetIntegra LifeSciences Holdings Corporation (IART) Stock Rating Lowered by TheStreet
www.americanbankingnews.com - October 28 at 10:16 AM
Edited Transcript of IART earnings conference call or presentation 26-Oct-17 12:30pm GMTEdited Transcript of IART earnings conference call or presentation 26-Oct-17 12:30pm GMT
finance.yahoo.com - October 27 at 6:27 AM
Integra LifeSciences Holdings Corporation (IART) Receives Buy Rating from Oppenheimer Holdings, Inc.Integra LifeSciences Holdings Corporation (IART) Receives Buy Rating from Oppenheimer Holdings, Inc.
www.americanbankingnews.com - October 26 at 4:08 PM
Integra LifeSciences Holdings Corporation (IART) Announces  Earnings ResultsIntegra LifeSciences Holdings Corporation (IART) Announces Earnings Results
www.americanbankingnews.com - October 26 at 12:34 PM
Integra Lifesciences Earns RS Rating UpgradeIntegra Lifesciences Earns RS Rating Upgrade
finance.yahoo.com - October 26 at 12:32 PM
Integra LifeSciences Reports Third Quarter 2017 Financial ResultsIntegra LifeSciences Reports Third Quarter 2017 Financial Results
finance.yahoo.com - October 26 at 12:32 PM
Integra misses Street 3Q forecastsIntegra misses Street 3Q forecasts
finance.yahoo.com - October 26 at 12:32 PM
INTEGRA LIFESCIENCES HOLDINGS CORP to Host Earnings CallINTEGRA LIFESCIENCES HOLDINGS CORP to Host Earnings Call
finance.yahoo.com - October 26 at 12:32 PM
Zacks Investment Research Lowers Integra LifeSciences Holdings Corporation (IART) to HoldZacks Investment Research Lowers Integra LifeSciences Holdings Corporation (IART) to Hold
www.americanbankingnews.com - October 25 at 7:52 PM
Integra LifeSciences Holdings Corporation (IART) Receives Average Recommendation of "Buy" from BrokeragesIntegra LifeSciences Holdings Corporation (IART) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - October 25 at 3:42 PM
Integra LifeSciences Holdings Corporation (IART) versus The Competition Financial AnalysisIntegra LifeSciences Holdings Corporation (IART) versus The Competition Financial Analysis
www.americanbankingnews.com - October 25 at 8:37 AM
Integra LifeSciences Holdings Corporation (IART) Expected to Announce Quarterly Sales of $286.27 MillionIntegra LifeSciences Holdings Corporation (IART) Expected to Announce Quarterly Sales of $286.27 Million
www.americanbankingnews.com - October 24 at 3:46 PM
Integra LifeSciences Holdings Corporation (IART) Expected to Post Earnings of $0.47 Per ShareIntegra LifeSciences Holdings Corporation (IART) Expected to Post Earnings of $0.47 Per Share
www.americanbankingnews.com - October 22 at 4:26 AM
Integra LifeSciences Holdings Corp. breached its 50 day moving average in a Bullish Manner : IART-US : October 19, 2017Integra LifeSciences Holdings Corp. breached its 50 day moving average in a Bullish Manner : IART-US : October 19, 2017
finance.yahoo.com - October 19 at 11:19 PM
Integra LifeSciences Holdings Corporation (IART) to Release Quarterly Earnings on ThursdayIntegra LifeSciences Holdings Corporation (IART) to Release Quarterly Earnings on Thursday
www.americanbankingnews.com - October 19 at 4:46 AM
Integra LifeSciences Holdings Corporation to Post Q3 2017 Earnings of $0.45 Per Share, Northcoast Research Forecasts (IART)Integra LifeSciences Holdings Corporation to Post Q3 2017 Earnings of $0.45 Per Share, Northcoast Research Forecasts (IART)
www.americanbankingnews.com - October 16 at 2:14 AM
Integra LifeSciences Holdings Corporations (IART) "Buy" Rating Reaffirmed at Jefferies Group LLCIntegra LifeSciences Holdings Corporation's (IART) "Buy" Rating Reaffirmed at Jefferies Group LLC
www.americanbankingnews.com - October 15 at 5:50 PM
Integra LifeSciences to Host Third Quarter 2017 Earnings Results Conference ...Integra LifeSciences to Host Third Quarter 2017 Earnings Results Conference ...
www.nasdaq.com - October 12 at 6:11 AM
Integra LifeSciences to Host Third Quarter 2017 Earnings Results Conference Call on October 26, 2017Integra LifeSciences to Host Third Quarter 2017 Earnings Results Conference Call on October 26, 2017
finance.yahoo.com - October 12 at 6:11 AM
Integra LifeSciences Holdings Corporation (IART) Upgraded to Buy by Zacks Investment ResearchIntegra LifeSciences Holdings Corporation (IART) Upgraded to Buy by Zacks Investment Research
www.americanbankingnews.com - October 10 at 4:34 PM
Integras (IART) Revize/Revize-X Boosts Tissue Technology ArmIntegra's (IART) Revize/Revize-X Boosts Tissue Technology Arm
finance.yahoo.com - October 10 at 12:46 AM
Integra LifeSciences Holdings Corporation (IART) Cut to Hold at Zacks Investment ResearchIntegra LifeSciences Holdings Corporation (IART) Cut to Hold at Zacks Investment Research
www.americanbankingnews.com - October 9 at 1:22 PM
Integra LifeSciences launches Revize™/ Revize™-X Collagen Matrix for Plastic and Reconstructive SurgeryIntegra LifeSciences launches Revize™/ Revize™-X Collagen Matrix for Plastic and Reconstructive Surgery
finance.yahoo.com - October 6 at 8:09 PM
Integra LifeSciences SurgiMend PRS Meshed Boosts ADM LineIntegra LifeSciences' SurgiMend PRS Meshed Boosts ADM Line
finance.yahoo.com - October 5 at 11:10 AM
 Analysts Expect Integra LifeSciences Holdings Corporation (IART) Will Post Quarterly Sales of $286.77 Million Analysts Expect Integra LifeSciences Holdings Corporation (IART) Will Post Quarterly Sales of $286.77 Million
www.americanbankingnews.com - October 5 at 10:36 AM
Integra LifeSciences launches SurgiMend® PRS Meshed Collagen Matrix for Plastic and Reconstructive SurgeryIntegra LifeSciences launches SurgiMend® PRS Meshed Collagen Matrix for Plastic and Reconstructive Surgery
finance.yahoo.com - October 4 at 4:01 PM
Integra LifeSciences Holdings Corp. breached its 50 day moving average in a Bearish Manner : IART-US : October 4, 2017Integra LifeSciences Holdings Corp. breached its 50 day moving average in a Bearish Manner : IART-US : October 4, 2017
finance.yahoo.com - October 4 at 4:01 PM
Integra LifeSciences' SurgiMend PRS Meshed Boosts ADM LineIntegra LifeSciences' SurgiMend PRS Meshed Boosts ADM Line
finance.yahoo.com - October 4 at 4:01 PM
Integra LifeSciences Launches Integra® SurgiMend™ PRS Meshed Collagen Matrix for Breast Reconstruction in EuropeIntegra LifeSciences Launches Integra® SurgiMend™ PRS Meshed Collagen Matrix for Breast Reconstruction in Europe
finance.yahoo.com - October 3 at 9:52 AM
Integra LifeSciences Launches Integra® SurgiMend(TM) PRS Meshed Collagen Matrix for Breast Reconstruction in EuropeIntegra LifeSciences Launches Integra® SurgiMend(TM) PRS Meshed Collagen Matrix for Breast Reconstruction in Europe
finance.yahoo.com - October 3 at 9:52 AM
Integra LifeSciences Completes the Acquisition of Codman Neurosurgery Business from Johnson & JohnsonIntegra LifeSciences Completes the Acquisition of Codman Neurosurgery Business from Johnson & Johnson
finance.yahoo.com - October 2 at 6:33 PM
FTC allows Integra to buy J&J’s Codman neuro business, with conditionsFTC allows Integra to buy J&J’s Codman neuro business, with conditions
www.reuters.com - September 28 at 3:44 PM

SEC Filings

Integra LifeSciences (NASDAQ:IART) SEC Filings

DateFilerForm TypeView
12/11/2017
6:05 AM
Integra LifeSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/08/2017
4:27 PM
Capital Research Global Investors (Filed by)
Integra LifeSciences (Subject)
Form SC 13G
View Filing

Social Media

Financials

Integra LifeSciences (NASDAQ:IART) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Integra LifeSciences (NASDAQ IART) Stock Chart for Monday, December, 11, 2017

Loading chart…

This page was last updated on 12/11/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.